These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6299129

  • 1. [Neuromuscular and cardiovascular effects of Duador, a new short-acting nondepolarizing muscle relaxant].
    Fitzal S, Ilias W, Kalina K, Schwarz S, Foldes FF, Steinbereithner K.
    Anaesthesist; 1982 Dec; 31(12):674-9. PubMed ID: 6299129
    [Abstract] [Full Text] [Related]

  • 2. A new short-acting non-depolarizing muscle relaxant (SZ1677) without cardiovascular side-effects.
    Vizi ES, Tuba Z, Mahó S, Foldes FF, Nagano O, Dóda M, Takagi S, Chaudhry IA, Saubermann AJ, Nagashima H.
    Acta Anaesthesiol Scand; 2003 Mar; 47(3):291-300. PubMed ID: 12648195
    [Abstract] [Full Text] [Related]

  • 3. Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia.
    Foldes FF, Nagashima H, Boros M, Tassonyi E, Fitzal S, Agoston S.
    Br J Anaesth; 1983 Mar; 55 Suppl 1():97S-103S. PubMed ID: 6190489
    [Abstract] [Full Text] [Related]

  • 4. The pharmacology of a new short-acting, non-depolarising muscle relaxant steroid (RGH-4201).
    Biró K, Kárpáti E.
    Arzneimittelforschung; 1981 Mar; 31(11):1918-24. PubMed ID: 6172135
    [Abstract] [Full Text] [Related]

  • 5. Clinical study of pancuronium as muscle relaxant in anesthesia.
    Park WY, Macnamara TE.
    Anesth Analg; 1973 Mar; 52(4):502-7. PubMed ID: 4123904
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neuromuscular and cardiovascular effects of atracurium administered to healthy horses anesthetized with halothane.
    Hildebrand SV, Arpin D.
    Am J Vet Res; 1988 Jul; 49(7):1066-71. PubMed ID: 3421529
    [Abstract] [Full Text] [Related]

  • 11. Clinical experiences with pipecuronium bromide.
    Boros M, Szenohradszky J, Kertész A, Marosi G, Tutsek L.
    Acta Chir Hung; 1983 Jul; 24(4):207-14. PubMed ID: 6322488
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuromuscular and cardiovascular effects of neostigmine and methyl-atropine administered at different degrees of rocuronium-induced neuromuscular block.
    Van den Broek L, Proost JH, Wierda JM, Njoo MD, Hennis PJ.
    Eur J Anaesthesiol; 1994 Nov; 11(6):481-7. PubMed ID: 7851356
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Pharmacology of various aminosteroidal muscle relaxants].
    Boumén U, Marshall I.
    Farmakol Toksikol; 1989 Nov; 52(3):29-33. PubMed ID: 2571518
    [Abstract] [Full Text] [Related]

  • 17. [Galanthamine hydrobromide in the reversion of nondepolarizing neuromuscular block].
    Pereira MA, Pena AA, Cardoso A, Freitas MJ, Ferro FN.
    Rev Bras Anestesiol; 1972 Nov; 22(1):10-9. PubMed ID: 4261779
    [No Abstract] [Full Text] [Related]

  • 18. Muscle relaxants: a clinical update.
    Buzello W, Diefenbach C, Nigrovic V.
    Acta Anaesthesiol Scand Suppl; 1996 Nov; 109():165-7. PubMed ID: 8901994
    [Abstract] [Full Text] [Related]

  • 19. The effect of dopamine and other catecholamines on neuromuscular transmission.
    Blum K.
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):297-306. PubMed ID: 4326551
    [No Abstract] [Full Text] [Related]

  • 20. Clinical neuromuscular pharmacology of AH 8165 D, an azobis-arylimidazo-pyridinium-compound.
    Schuh FT.
    Anaesthesist; 1975 Apr; 24(4):151-6. PubMed ID: 237423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.